BioAegis Therapeutics and EastHORN Expand Phase 2 COVID-19 Clinical Trial within Spain and into Romania
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
BioAegis’ Phase 2 clinical trial of recombinant human plasma...
EastHORN is pleased to announce its participation at this ye...
EastHORN is pleased to announce its participation at this ye...
EastHORN is pleased to announce its participation to SCOPE S...